Article Information
History
- June 16, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Bricout Hélène1,*,
- Levant Marie-Cécile1,
- Assi Nada2,
- Crépey Pascal3,
- Descamps Alexandre4,
- Mari Karine1,
- Gaillat Jacques5,
- Gavazzi Gaétan6,7,
- Grenier Benjamin2,
- Launay Odile4,
- Mosnier Anne8,
- Raguideau Fanny2,
- Watier Laurence9,
- Rebecca C Harris10 and
- Chit Ayman1,11
- 1Sanofi Vaccines, France
- 2HEVA, Pôle Epidémiologie, Lyon
- 3Ecole des hautes études en santé publique, CNRS, Université de Rennes, ARENES - UMR 6051, Recherche sur les services et le management en santé – Inserm U 1309, Rennes, France
- 4Inserm CIC 1417, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Université Cité Paris, Paris, France
- 5Service de Maladies Infectieuses, Centre Hospitalier Annecy Genevois, Annecy, France
- 6CHU Grenoble Alpes, Service Universitaire de Gériatrie Clinique, CS 10217, Grenoble, France
- 7Laboratoire T-Raig TIMC-IMAG CNRS 5525 Université Grenoble-Alpes, France
- 8Open Rome, Paris, France
- 9Epidemiology and modelling of bacterial escape to antimicrobials, Institut Pasteur, Paris
- 10Sanofi Vaccines, Singapore
- 11Leslie Dan Faculty of Pharmacy, University of Toronto, Canada
- ↵*Corresponding Author: Bricout Hélène; 14, Espace Henry Vallée, 69007 Lyon, France; Helene.bricout{at}sanofi.com